Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Operating CF Margin

-677.64%

Quarterly · Period ending:

LCTX logo

LCTX Operating CF Margin

Latest reported-677.64%
LCTX Quarterly Operating CF Margin (0.00% → -677.64%)
High-resolution chart · PNG

LCTX operating cf margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Operating CF Margin — Quarterly
Period endingOperating CF Margin
-677.6427%
-468.2898%
-73.8196%
-98.2342%
-200.3255%
-325.2996%
-221.2692%
-153.1358%
-367.6136%
-400.4848%
-288.2663%
-404.2536%
-194.3566%
-471.1651%
-433.577%
-182.7885%
-155.1065%
418.2547%
-611.7708%
-220.1635%
-1,228.1179%
-2,533.7884%
-3,398.1928%
-1,417.2515%
-4,281.8182%
-3,027.7108%
-663.8221%
-3,429.9539%
-3,866.8%
-5,203.352%
-3,398.8304%
-2,777.2727%
-1,221.1221%
-2,756.8%
-997.3638%
-1,658.9633%
-2,378.7402%
-2,136.6755%
-1,167.81%
-2,285.8974%
-2,024.9012%
-2,442.4915%
-2,512.973%
-1,376.3095%
-1,742.5138%
-1,603.3558%
-2,050.9027%
-1,583.8813%
-2,309.57%
-2,109.5269%
-684.4698%
-1,158.9741%
-1,423.6642%
-1,339.6398%
-964.1867%
-499.1038%
-382.8851%
-904.6555%
-220.437%
-314.5428%
-369.9895%
-437.4621%
-195.7188%
-245.1784%
-254.3519%
-159.8928%
-112.8417%
-326.1474%
-215.4014%
-345.6813%
-179.362%
-74.7378%
-122.5714%
-70.9281%
-98.8785%
-66.3967%
-166.0987%
-155.4583%
-39.538%
-80.1156%
-62.6488%
-308.078%
156.8626%
-274.8403%
-177.8068%
-344.8742%
-103.1903%
-106.9855%
-198.1099%
-588.6366%
-183.8038%
483.4259%
-164.4655%
-580.5231%
-280.0197%
-541.5677%
-799.4787%
-1,162.3622%
-537.4338%
-3,037.6483%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.